Company

 

PhageTech, Inc. is a Southern California company founded in 2014. PhageTech’s core technology was developed by two world-class researchers at the University of California, Irvine supported by a team of research scientists, postdoctoral researchers and graduate students. The collaboration between Dr. Reginald Penner and Dr. Gregory Weiss brought together two experts in analytical chemistry and molecular recognition.

​

The original core bioconducting technology was developed over ten years of intensive NIH-funded research, made possible through $2.2M in grants awarded to Dr. Penner and Dr. Weiss. PhageTech, Inc. evolved the technology to the CarePoint-Assay, an electrochemical point-of-care sandwich ELISA sensor system that will enable rapid and sensitive detection of disease biomarkers at their early stages.